연구성과로 돌아가기

2021 연구자 정보 (17 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Venkatanarayan, Avinashnarayan
(Venkatanarayan, A) ⓘ 		Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Venkatramanan, K.
(Venkatramanan, K) ⓘ 		SCSVMV Deemed Univ, Dept Phys, Kanchipuram 631561, Tamil Nadu, India ⓘ N-4628-2016
kannan, venkatramanan ⓘ
ⓘ 		[JCR상위 0.7] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics ⓘ SCIE ⓘ 0.7 CHEMISTRY, APPLIED;CHEMISTRY, PHYSICAL;ENERGY & FUELS;ENGINEERING, CHEMICAL ⓘ SaiAnand.Gopalan@newcastle.edu.au;Quinn.Qiao@sdstate.edu; ⓘ
Western, Luke M.
(Western, LM) ⓘ 		교신저자 Univ Bristol, Sch Chem, Bristol, Avon, England ⓘ
ⓘ 		0000-0002-0043-711X
Western, Luke ⓘ 		[JCR상위 0.7] A decline in emissions of CFC-11 and related chemicals from eastern China ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ Luke.western@bristol.ac.uk;rprinn@mit.edu;matt.rigby@bristol.ac.uk; ⓘ
Wilson, Gregory J.
(Wilson, GJ) ⓘ 		Newcastle Energy Ctr, CSIRO Energy, 10 Murray Dwyer Cct, Mayfield West, NSW 2304, Australia ⓘ G-3005-2013
Wilson, Gregory ⓘ 		0000-0003-2575-5488
Wilson, Gregory ⓘ 		[JCR상위 0.7] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics ⓘ SCIE ⓘ 0.7 CHEMISTRY, APPLIED;CHEMISTRY, PHYSICAL;ENERGY & FUELS;ENGINEERING, CHEMICAL ⓘ SaiAnand.Gopalan@newcastle.edu.au;Quinn.Qiao@sdstate.edu; ⓘ
Yan, Yibing
(Yan, YB) ⓘ 		Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Ye, Xin
(Ye, X) ⓘ 		Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Yen, Ivana
(Yen, I) ⓘ 		제1저자 Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Yi, Kijong
(Yi, K) ⓘ 		Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Yin, Jianping
(Yin, JP) ⓘ 		Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Youk, Jeonghwan
(Youk, J) ⓘ 		Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Zhang, Liangxuan
(Zhang, LX) ⓘ 		Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Acharya, Suman
(Acharya, S) ⓘ 		Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea ⓘ 		AAP-4838-2020
Acharya, Suman ⓘ
ⓘ 		[JCR상위 0.8] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis ⓘ 		SCIE ⓘ 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;ONCOLOGY
IMMUNOLOGY ⓘ 		hjko@kangwon.ac.kr;jchang@yu.ac.kr;
jchang@yu.ac.kr; ⓘ
Ahn, Jae-Hee
(Ahn, JH) ⓘ 		Kangwon Natl Univ, Dept Pharm, Kangwondaehak Gil 1, Chunchon 24341, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.8] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway ⓘ SCIE ⓘ 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;ONCOLOGY ⓘ hjko@kangwon.ac.kr;jchang@yu.ac.kr; ⓘ
Chang, Jae-Hoon
(Chang, JH) ⓘ 		교신저자 Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.8] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis ⓘ 		SCIE ⓘ 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;ONCOLOGY
IMMUNOLOGY ⓘ 		hjko@kangwon.ac.kr;jchang@yu.ac.kr;
jchang@yu.ac.kr; ⓘ
Gu, Ye
(Gu, Y) ⓘ 		Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.8] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis ⓘ 		SCIE ⓘ 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;ONCOLOGY
IMMUNOLOGY ⓘ 		hjko@kangwon.ac.kr;jchang@yu.ac.kr;
jchang@yu.ac.kr; ⓘ
페이지 이동: